Loading Events

Identifying Knowledge Gaps in Chronic Osteoarthritis Pain in Women

  • This event has passed.

January 27, 2020 - January 28, 2020

Chronic pain disproportionately affects women, and substantial research demonstrates that differences exist between women and men in pain perception, management, and treatment. SWHR will convene a diverse group of interdisciplinary researchers and clinicians for a closed-door roundtable meeting on osteoarthritic pain in women and how underlying biological responses to pain in women may lead to functional decline in the context of work, home, social, and personal life. The goal of the panel is to identify unmet needs and knowledge gaps in understanding the relationship between pain and function in women with osteoarthritis, and to explore the best means to use scientific evidence to improve comprehensive, function-based pain management for those with osteoarthritis.

Details

Start:
January 27, 2020
End:
January 28, 2020
Event Categories:
, ,

Venue

Cosmos Club
2121 Massachusetts Ave NW
Washington, DC 20008 United States

Organizer

SWHR

Objectives

  • Highlight the current state of the science of chronic osteoarthritic pain in women
  • Explore the impact of chronic osteoarthritic pain and its effect on women’s functioning
  • Identify knowledge gaps in research, policy, and education
  • Make recommendations to address these gaps, including public policy and outreach effort

Roundtable Participants

Daniel Clauw, MD, Professor of Anesthesiology, Medicine and Psychiatry, University of Michigan

Roger B. Fillingim, PhD, Director, University of Florida Pain Research & Intervention Center of Excellence

Anne-Marie Malfait, MD, PhD, Professor of Medicine and Chair of Arthritis, Rush University

Tuhina Neogi, MD, PhD, Chief of Rheumatology, Boston University School of Medicine

Daniel L. Riddle, PT, PhD, Professor of Physical Therapy, Orthopaedic Surgery and Rheumatology, Virginia Commonwealth University

Sponsors

This program is supported by an educational sponsorship from Eli Lilly & Company, Teva, and Regeneron. SWHR maintains editorial control and independence over educational content.

Lilly Logo